These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32427268)

  • 1. Microfluidic assessment of red blood cell mediated microvascular occlusion.
    Man Y; Kucukal E; An R; Watson QD; Bosch J; Zimmerman PA; Little JA; Gurkan UA
    Lab Chip; 2020 Jun; 20(12):2086-2099. PubMed ID: 32427268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A miniaturized wash-free microfluidic assay for electrical impedance-based assessment of red blood cell-mediated microvascular occlusion.
    Oshabaheebwa S; Delianides CA; Patwardhan AA; Evans EN; Sekyonda Z; Bode A; Apio FM; Mutuluuza CK; Sheehan VA; Suster MA; Gurkan UA; Mohseni P
    Biosens Bioelectron; 2024 Aug; 258():116352. PubMed ID: 38718635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardized microfluidic assessment of red blood cell-mediated microcapillary occlusion: Association with clinical phenotype and hydroxyurea responsiveness in sickle cell disease.
    Man Y; Kucukal E; An R; Bode A; Little JA; Gurkan UA
    Microcirculation; 2021 Feb; 28(2):e12662. PubMed ID: 33025653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microfluidic electrical impedance assessment of red blood cell-mediated microvascular occlusion.
    Man Y; Maji D; An R; Ahuja SP; Little JA; Suster MA; Mohseni P; Gurkan UA
    Lab Chip; 2021 Mar; 21(6):1036-1048. PubMed ID: 33666615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OcclusionChip: A functional microcapillary occlusion assay complementary to ektacytometry for detection of small-fraction red blood cells with abnormal deformability.
    Man Y; An R; Monchamp K; Sekyonda Z; Kucukal E; Federici C; Wulftange WJ; Goreke U; Bode A; Sheehan VA; Gurkan UA
    Front Physiol; 2022; 13():954106. PubMed ID: 36091387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic storage of donor red cells preserves deformability after exposure to plasma from adults with sickle cell disease.
    Karafin MS; Field JJ; Ilich A; Li L; Qaquish BF; Shevkoplyas SS; Yoshida T
    Transfusion; 2023 Jan; 63(1):193-202. PubMed ID: 36310401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GBT440 improves red blood cell deformability and reduces viscosity of sickle cell blood under deoxygenated conditions.
    Dufu K; Patel M; Oksenberg D; Cabrales P
    Clin Hemorheol Microcirc; 2018; 70(1):95-105. PubMed ID: 29660913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microconfined flow behavior of red blood cells.
    Tomaiuolo G; Lanotte L; D'Apolito R; Cassinese A; Guido S
    Med Eng Phys; 2016 Jan; 38(1):11-6. PubMed ID: 26071649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry.
    Rab MAE; van Oirschot BA; Bos J; Kanne CK; Sheehan VA; van Beers EJ; van Wijk R
    J Vis Exp; 2019 Nov; (153):. PubMed ID: 31762454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic deformability of sickle red blood cells in microphysiological flow.
    Alapan Y; Matsuyama Y; Little JA; Gurkan UA
    Technology (Singap World Sci); 2016 Jun; 4(2):71-79. PubMed ID: 27437432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model.
    Dufu K; Alt C; Strutt S; Partridge J; Tang T; Siu V; Liao-Zou H; Rademacher P; Williams AT; Muller CR; Geng X; Pochron MP; Dang AN; Cabrales P; Li Z; Oksenberg D; Cathers BE
    Br J Haematol; 2023 Jul; 202(1):173-183. PubMed ID: 36960712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in red blood cell deformability during storage: a microfluidic approach.
    Cluitmans JC; Chokkalingam V; Janssen AM; Brock R; Huck WT; Bosman GJ
    Biomed Res Int; 2014; 2014():764268. PubMed ID: 25295273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated automated particle tracking microfluidic enables high-throughput cell deformability cytometry for red cell disorders.
    Guruprasad P; Mannino RG; Caruso C; Zhang H; Josephson CD; Roback JD; Lam WA
    Am J Hematol; 2019 Feb; 94(2):189-199. PubMed ID: 30417938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.
    Hebert N; Rakotoson MG; Bodivit G; Audureau E; Bencheikh L; Kiger L; Oubaya N; Pakdaman S; Sakka M; Di Liberto G; Chadebech P; Vingert B; Pirenne F; Galactéros F; Cambot M; Bartolucci P
    Am J Hematol; 2020 Nov; 95(11):1235-1245. PubMed ID: 32681733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
    Nader E; Romana M; Connes P
    Front Immunol; 2020; 11():454. PubMed ID: 32231672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between red blood cell deformability metrics and perfusion of an artificial microvascular network.
    Sosa JM; Nielsen ND; Vignes SM; Chen TG; Shevkoplyas SS
    Clin Hemorheol Microcirc; 2014; 57(3):275-89. PubMed ID: 23603326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurements of red cell deformability and hydration reflect HbF and HbA
    Parrow NL; Tu H; Nichols J; Violet PC; Pittman CA; Fitzhugh C; Fleming RE; Mohandas N; Tisdale JF; Levine M
    Blood Cells Mol Dis; 2017 Jun; 65():41-50. PubMed ID: 28472705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Size and density measurements of single sickle red blood cells using microfluidic magnetic levitation.
    Goreke U; Bode A; Yaman S; Gurkan UA; Durmus NG
    Lab Chip; 2022 Feb; 22(4):683-696. PubMed ID: 35094036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic capillary networks are more sensitive than ektacytometry to the decline of red blood cell deformability induced by storage.
    Piety NZ; Stutz J; Yilmaz N; Xia H; Yoshida T; Shevkoplyas SS
    Sci Rep; 2021 Jan; 11(1):604. PubMed ID: 33436749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease.
    Schroeder P; Fulzele K; Forsyth S; Ribadeneira MD; Guichard S; Wilker E; Marshall CG; Drake A; Fessler R; Konstantinidis DG; Seu KG; Kalfa TA
    J Pharmacol Exp Ther; 2022 Mar; 380(3):210-219. PubMed ID: 35031585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.